IQVIA: As use of AI, ML and NLP increases - compliance must keep up
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
Uwe Trinks Regulatory Technology European Court European Union Product Development European Commission
Source: outsourcing-pharma.com